Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Patent
1996-04-29
1997-10-14
Degen, Nancy
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
4352351, 435375, 536 231, 536 241, C12N 510, C12N 701, C07H 2104
Patent
active
056771789
ABSTRACT:
Methods and compositions for treating neoplastic conditions by viral-based therapy are provided. Mutant virus lacking viral proteins which bind and/or inactivate p53 or RB are administered to a patient having a neoplasm which comprises cells lacking p53 and/or RB function. The mutant virus is able to substantially produce a replication phenotype in neoplastic cells but is substantially unable to produce a replication phenotype in non-replicating, non-neoplastic cells having essentially normal p53 and/or RB function. The preferential generation of replication phenotype in neoplastic cells results in a preferential killing of the neoplastic cells, either directly or by expression of a cytotoxic gene in cells expressing a viral replication phenotype.
REFERENCES:
Shingu et al (1991) J Ger Virol 72 2031-2034.
Matuza et al (1991) Science 252: 854-856.
Horwitz 1985 Virology Chapter 24 477-495.
Whyte et al (1989) Cell vol. 56 67-75.
Burk & Barker 1987 Virology 156:107-121.
Smith et al., Studies on the Use of Viruses in the Treatment of Carcinoma of the Cervix, Cancer, vol. 9, pp. 1211-1218 (1956).
Newman et al., Virus Treatment in Advanced Cancer, Cancer, vol. 7, pp. 106-118, (1954).
Alice E. Moore, Effects of Viruses on Tumors, Ann Rev Microbiol, vol. 8, pp. 393-410 (1954).
F. L. Graham, Transformation by and Oncogenicity of Human Adenoviruses, The Adenoviruses, Chapter 9, pp. 339-383 (1984).
Bjorn et al., Selective Elimination of Breast Cancer Cells from Human Bone Marrow Using an Antibody-Pseudomonas, Cancer Research, vol. 50, pp. 5992-5996, (1990).
Degen Nancy
Giotta Gregory
ONYX Pharmaceuticals, Inc.
Torchia Timothy E.
LandOfFree
Cytopathic viruses for therapy and prophylaxis of neoplasia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytopathic viruses for therapy and prophylaxis of neoplasia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytopathic viruses for therapy and prophylaxis of neoplasia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1554460